Chatham Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

Chatham Capital Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,929	Closed	-$232K	–	160
2019 Q4	$232K	Buy	+1,929	New	+$215K	0.06%	156
2019 Q3	–	Sell	-1,854	Closed	-$202K	–	159
2019 Q2	$202K	Buy	+1,854	New	+$197K	0.05%	156
2018 Q4	–	Sell	-1,779	Closed	-$217K	–	156
2018 Q3	$217K	Sell	1,779 -180	-9%	-$21.2K	0.05%	150
2018 Q2	$215K	Hold	1,959	–	–	0.06%	148
2018 Q1	$209K	Hold	1,959	–	–	0.06%	146
2017 Q4	$209K	Hold	1,959	–	–	0.06%	142
2017 Q3	$218K	Hold	1,959	–	–	0.06%	143
2017 Q2	$202K	Buy	+1,959	New	+$193K	0.06%	149
2015 Q2	–	Sell	-3,300	Closed	-$378K	–	152
2015 Q1	$378K	Buy	+3,300	New	+$364K	0.11%	127

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Chatham Capital Group's IBB Position: Q1 2020 in Review

Chatham Capital Group sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 1,929 shares — an estimated $232K sold.

Chatham Capital Group first reported a position in IBB in Q1 2015 and held it in 9 quarters. The position peaked at $378K in Q1 2015. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

Chatham Capital Group reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
Chatham Capital Group sold 1,929 iShares Biotechnology ETF shares in Q1 2020, an estimated $232K.
Chatham Capital Group first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 9 quarters.
Chatham Capital Group's iShares Biotechnology ETF position peaked at $378K in Q1 2015.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Chatham Capital Group's 13F filing for Q1 2020, filed 1 May 2020.